SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-19-000360
Accepted
2019-03-05 00:15:09
Documents
1
Effectiveness Date
2019-03-04
Registration Form
F-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 592
  Complete submission text file 9999999995-19-000360.txt   1892
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-227752 | Film No.: 19656516
SIC: 2834 Pharmaceutical Preparations